Tailored Health Self-Management Interventions for Highly Distressed Caregivers: Family Members of Persons With Dementia

July 18, 2022 updated by: Jaclene A. Zauszniewski, Case Western Reserve University
How do different health self-management interventions (resourcefulness training or biofeedback training) compare to usual care (dementia education) in affecting the health risks, and physical and mental health, of family caregivers of people with dementia? And, how do those health outcomes compare with similar measures for family caregivers of people with bipolar disorder? This one-year supplement study will exam these two aims as part of a larger four-year parent grant (NCT03023332). Caregivers enrolled in the study will be randomized to one of the three self-management interventions, with two data collections time points pre- and post-intervention.

Study Overview

Detailed Description

With every passing minute, a family member in the United States becomes an informal caregiver for an elder with Alzheimer's disease or another related dementia, which can be highly distressing and adversely affect the caregiver's mental and physical health. Similar to caregivers of persons with bipolar disorder, who are currently participating in the parent study for which this supplement is proposed, caregivers of persons with Alzheimer's or related dementia have been found to experience greater distress than caregivers of persons with other chronic conditions. They have significantly more mental and physical health problems than the general population, leading to greater use of mental health and primary care services and resulting in their inability to continue to provide care for their family members. Thus, although the trajectories of the two conditions (bipolar disorder versus dementia) may differ, we propose that caregivers of persons with dementia may benefit similarly from tailored health self-management interventions, including resourcefulness skills or biofeedback training, more than the educational materials or programs they are typically offered. Therefore, the caregivers of persons with Alzheimer's disease or related dementia to be sampled in this administrative supplement will comprise an additional study arm for the randomized controlled trial constituting the parent study. They will be randomized to: 1) usual care (education program), 2) resourcefulness training, or 3) biofeedback. Three outcomes (health risk, mental health, and physical health) will be assessed at baseline and post-intervention.

Study aims are to:

  1. Examine the effectiveness of resourcefulness training and biofeedback versus usual care (education program) in family caregivers of persons with Alzheimer's disease or related dementia;
  2. Compare the effects of usual care, resourcefulness training, and biofeedback obtained in caregivers of persons with dementia with those of the caregivers of persons with bipolar disorder from the parent study; and
  3. Explore differences between the two types of caregivers on their needs (determined by their lowest baseline cut score on measures of knowledge, resourcefulness, and heart rate variability) and preferences (determined by asking which intervention they would have chosen) among education, resourcefulness training, or biofeedback.

Repeated measures analyses and descriptive statistics will address the study aims. Our findings will generate new scientific knowledge about the effectiveness of novel, easy to use, independently performed interventions that can be individualized and self-tailored to promote the health of Alzheimer's caregivers and other comparably distressed family caregivers.

Study Type

Interventional

Enrollment (Actual)

311

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ohio
      • Cleveland, Ohio, United States, 44106
        • Case Western Reserve University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • At least 18 years old
  • Have a living family member with Alzheimer's disease or another dementia
  • Identify self as a primary caregiver
  • In-home caregivers: must be currently providing a minimum of 4 hours per day of supervision/direct care for at least the last 6 months. Caregivers whose family member lives within a facility: must report visiting their care recipient at least once per week for at least the last 6 months.
  • Be capable of performing informed consent and participating in study procedures

Exclusion Criteria:

  • Does not have family member with Alzheimer's disease or another dementia
  • Has not cared for a living family member for at least the last 6 months.
  • Has knowledge of another family member in the same household enrolled in the study
  • Currently pregnant
  • Has a pacemaker
  • Lives outside of the study area

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: Usual Care
An educational program designed to teach family caregivers about the characteristics, types, causes, and risk factors of dementia, as well as teach about health promotion, the stages of dementia, behavior changes, communicating with a family member with dementia, and caring for oneself. The content to be presented within an audiovisual format using a tablet computer follows recommendations and guidelines developed through research and by the Alzheimer's Association and the National Institute on Aging.
EXPERIMENTAL: Self-Management
Use of a heart-rate variability (HRV) tracking device to enable one to learn to alter physiology to improve health. Devices are used to measure physiological activity, e.g., breathing and heart function, and provide rapid, accurate "feedback" to the user, thereby enabling desired physiological changes that can endure over time without continued use of the device and to continue to influence behavior.
A cognitive-behavioral intervention presented within an audiovisual format using a tablet computer that consists of teaching and reinforcing personal (self-help) and social (help-seeking) resourcefulness skills.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Global Health - PROMIS (Patient Reported Outcomes Measurement Information System)
Time Frame: From T1 (baseline) through T2 (30 days post-intervention)
Measure of Caregiver's Global Health: 5 items - physical health; 5 items - mental health; 5-point scale; Scores range 0-40; higher score indicates better health
From T1 (baseline) through T2 (30 days post-intervention)
Change in Health Risk Behavior Scale
Time Frame: From T1 (baseline) through T2 (30 days post-intervention)
Measure of Caregiving Health Risks: 9 items; 3-point scale, Scores range 9-27; higher score indicates greater risk
From T1 (baseline) through T2 (30 days post-intervention)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Involvement Evaluation Questionnaire
Time Frame: From T1 (baseline) through T2 (30 days post-intervention)
Measure of Caregiving Involvement:31 items; four subscales (5-point scale); Scores range 0-124; higher score indicates more involvement
From T1 (baseline) through T2 (30 days post-intervention)
Change in Dementia Knowledge Assessment Scale
Time Frame: From T1 (baseline) through T2 (30 days post-intervention)
Measure of Dementia Knowledge: 25 items; true-false (5-point scale); Scores range 25-125; higher score indicates better knowledge
From T1 (baseline) through T2 (30 days post-intervention)
Change in Heart Rate Variability
Time Frame: From T1 (baseline) through T2 (30 days post-intervention)
Change in Heart Rate Variability: time-domain parameters and frequency domain parameters are combined into a single index score
From T1 (baseline) through T2 (30 days post-intervention)
Change in Resourcefulness Scale
Time Frame: From T1 (baseline) through T2 (30 days post-intervention)
Measure of Resourcefulness: 28 items; 6-point scale; Scores range 0-140; higher score indicates more resourcefulness
From T1 (baseline) through T2 (30 days post-intervention)
Change in Care Recipient Dementia Symptoms / Behaviors
Time Frame: From T1 (baseline) through T2 (30 days post-intervention)
Measure of Revised Memory and Behaviors Checklist: 24 items; subscale measuring frequency (5-point scale) of behaviors; Scores range 0-120; higher score indicates more symptoms / behaviors
From T1 (baseline) through T2 (30 days post-intervention)
Change in Caregiver Reactions
Time Frame: From T1 (baseline) through T2 (30 days post-intervention)
Measure of Revised Memory and Behaviors Checklist: 24 items; subscale measuring reaction (5-point scale) of behaviors; Scores range 0-120; higher score indicates greater reaction
From T1 (baseline) through T2 (30 days post-intervention)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

August 29, 2019

Primary Completion (ACTUAL)

June 21, 2022

Study Completion (ACTUAL)

June 21, 2022

Study Registration Dates

First Submitted

January 24, 2020

First Submitted That Met QC Criteria

January 28, 2020

First Posted (ACTUAL)

January 30, 2020

Study Record Updates

Last Update Posted (ACTUAL)

July 20, 2022

Last Update Submitted That Met QC Criteria

July 18, 2022

Last Verified

July 1, 2022

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Carer Stress Syndrome

Clinical Trials on Biofeedback Training

3
Subscribe